Table 2.
Pretreatment | Mean EC50 (nM) |
95% confidence limits (nM) |
Mean Emax (%) |
95% confidence limits (nM) |
n |
---|---|---|---|---|---|
vehicle | 15.4 | 9.7–24.6 | 98.7 | 92.4–105.2 | 10 |
0.01 nM IRN | 18.2 | 10.5–31.5 | 101.6 | 95.3–107.7 | 10 |
vehicle | 14.3 | 9.2–22.1 | 97.8 | 92.5–103.3 | 9 |
0.1 nM IRN | 28.7 | 15.5–53.2 | 120.3** | 113.0–127.9 | 9 |
vehicle | 13.9 | 7.8–24.8 | 98.3 | 90.5–106.4 | 10 |
1 nM IRN | 26.3 | 14.5–47.9 | 132.9** | 123.4–142.8 | 10 |
vehicle | 15.8 | 8.9–27.8 | 99.7 | 93.2–106.4 | 10 |
10 nM IRN | 32.4 | 17.9–58.8 | 124.8** | 117.3–132.2 | 10 |
vehicle | 15.6 | 9.6–25.3 | 101.7 | 94.5–109.1 | 9 |
100 nM IRN | 16.3 | 9.4–28.3 | 104.8 | 98.0–110.9 | 9 |
**p < 0.01, compared with respective vehicle group (values in the previous row). See also Figure 8.